<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29853627</article-id>
<article-id pub-id-type="pmc">6021990</article-id>
<article-id pub-id-type="publisher-id">0149-18</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.0149-18.2018</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
<subj-group>
<subject>Neurobiology of Disease</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Chemogenetic Activation of Prefrontal Cortex Rescues Synaptic and Behavioral Deficits in a Mouse Model of 16p11.2 Deletion Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-9202-4469</contrib-id>
<name>
<surname>Rein</surname>
<given-names>Benjamin</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0001-6769-8130</contrib-id>
<name>
<surname>Zhang</surname>
<given-names>Freddy</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-4571-3296</contrib-id>
<name>
<surname>Tan</surname>
<given-names>Tao</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhong</surname>
<given-names>Ping</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qin</surname>
<given-names>Luye</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-3519-9596</contrib-id>
<name>
<surname>Yan</surname>
<given-names>Zhen</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<aff id="aff1">Department of Physiology and Biophysics, State University of New York at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York 14214</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Zhen Yan at the above address.
<email>zhenyan@buffalo.edu</email></corresp>
<fn fn-type="con">
<p>Author contributions: B.R. wrote the first draft of the paper; Z.Y. edited the paper; Z.Y. designed research; W.W., B.R., F.Z., T.T., P.Z., and L.Q. performed research; W.W., B.R., F.Z., T.T., and P.Z. analyzed data; Z.Y. wrote the paper.</p>
</fn>
<fn fn-type="equal" id="FN1">
<p>*W.W. and B.R. contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>27</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>27</day>
<month>12</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>38</volume>
<issue>26</issue>
<fpage>5939</fpage>
<lpage>5948</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>30</day>
<month>4</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 the authors 0270-6474/18/385939-10$15.00/0</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="zns02618005939.pdf"></self-uri>
<abstract>
<p>Microdeletion of the human 16p11.2 gene locus has been linked to autism spectrum disorder (ASD) and intellectual disability and confers risk for a number of other neurodevelopmental deficits. Transgenic mice carrying 16p11.2 deletion (<italic>16p11</italic><sup>+/−</sup>) display phenotypes reminiscent of those in human patients with 16p11.2 deletion syndrome, but the molecular mechanisms and treatment strategies for these phenotypes remain unknown. In this study, we have found that both male and female <italic>16p11</italic><sup>+/−</sup> mice exhibit deficient NMDA receptor (NMDAR) function in the medial prefrontal cortex (mPFC), a brain region critical for high-level “executive” functions. Elevating the activity of mPFC pyramidal neurons with a CaMKII-driven Gq-DREADD (Gq-coupled designer receptors exclusively activated by designer drugs) led to the significant increase of NR2B subunit phosphorylation and the restoration of NMDAR function, as well as the amelioration of cognitive and social impairments in <italic>16p11</italic><sup>+/−</sup> mice. These results suggest that NMDAR hypofunction in PFC may contribute to the pathophysiology of 16p11.2 deletion syndrome and that restoring PFC activity is sufficient to rescue the behavioral deficits.</p>
<p><bold>SIGNIFICANCE STATEMENT</bold> The 16p11.2 deletion syndrome is strongly associated with autism spectrum disorder and intellectual disability. Using a mouse model carrying the 16p11.2 deletion, <italic>16p11</italic><sup>+/−</sup>, we identified NMDA receptor hypofunction in the prefrontal cortex (PFC). Elevating the activity of PFC pyramidal neurons with a chemogenetic tool, Gq-DREADD, led to the restoration of NMDA receptor function and the amelioration of cognitive and social impairments in <italic>16p11</italic><sup>+/−</sup> mice. These results have revealed a novel route for potential therapeutic intervention of 16p11.2 deletion syndrome.</p>
</abstract>
<kwd-group>
<kwd>16p11.2 deletion</kwd>
<kwd>autism spectrum disorder</kwd>
<kwd>DREADD</kwd>
<kwd>NMDA</kwd>
<kwd>prefrontal cortex</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>